Wordt geladen...

A111 INFLIXIMAB FOR INDUCTION OF REMISSION IN CROHN’S DISEASE

BACKGROUND: Crohn’s disease (CD) is a chronic idiopathic disease characterized by transmural inflammation of the gastrointestinal tract. AIMS: To evaluate the efficacy and safety of infliximab (IFX) for induction of remission in CD. METHODS: MEDLINE, EMBASE, the Cochrane Library were searched from d...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:J Can Assoc Gastroenterol
Hoofdauteurs: Deol, N, Nguyen, T, Parker, C E, Khanna, R, MacDonald, J, Feagan, B G, Jairath, V
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: Oxford University Press 2018
Onderwerpen:
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6507942/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jcag/gwy008.112
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!